CLINICAL_TRIALS
trial_result
· 2016-01-13
Clinical Trial Update: Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA [Phase 2]
Summary
Phase 2 trial assessing oral methylene blue MMX tablets in colorectal cancer completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cosmo Technologies Ltd | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-01-13